期刊文献+

帕瑞昔布的合成 被引量:5

Synthesis of Parecoxib
原文传递
导出
摘要 用1,2-二苯乙酮为原料,与氯磺酸反应得1-苯基-2-(4-磺酸基苯基)乙酮,在吡啶作用下与乙酰氯缩合制得1-苯基-2-(4-磺酸基苯基)-2-乙酰基乙酮,与盐酸羟胺环合得4-(5-甲基-3-苯基异噁唑-4-基)苯磺酸,经氯化、氨解制得伐地昔布,最后与丙酸酐反应制得帕瑞昔布,总收率约23%。 Parecoxib was synthesized from 1,2-diphenylethanone by reaction with chlorosulfonic acid, condensation with acetyl chloride in the presence of pyridine and cyclization with hydroxylamine hydrochloride to give 4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonic acid, which was subjected to chlorination and ammonolysis to afford valdecoxib, followed by reaction with propionic anhydride with an overall yield of about 23%.
机构地区 武汉工程大学
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第12期1207-1209,共3页 Chinese Journal of Pharmaceuticals
关键词 帕瑞昔布 环氧合酶-2 抑制剂 合成 parecoxib cyclooxygenase-2 inhibitor synthesis
  • 相关文献

参考文献9

  • 1封宇飞,雷静,吕俊玲,李可欣,傅得兴.特异性环氧酶-2抑制剂——帕瑞昔布[J].中国临床药理学杂志,2003,19(3):207-210. 被引量:64
  • 2王凯,宋率华,金琪,黄婷.帕瑞昔布钠合成路线图解[J].中国医药工业杂志,2013,44(8):836-838. 被引量:14
  • 3Letendre L J, Snoddy CK, Klemm George H, et al. Method for the preparation of diarylisoxazole sulfonamide compounds and intermediates: WO, 2005123701 [P]. 2005-12-29. 被引量:1
  • 4Sundaram V, Bhimireddy A, Eswaraiah S, et al. A method for preparing 3,4-diphenylsubstituted isoxazole derivatives such as valdecoxib, parecoxib, and their intermediates: EP, 1550658 [P]. 2005-07-06. 被引量:1
  • 5Thakashinamoorthy C, Jesudoss MG, a M, et al. A novel process for preparing valdecoxib: WO, 2005085218 [P]. 2005-09-15. 被引量:1
  • 6Koboldt M, Talley JJ, Seibert K, et al. N-[ [ (5-Methyl-3- phenylisoxazol-4-yl) penyl] sulfonyl] -phropanamide, sodiun salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration [J]. J Med Chem, 2000, 43 (5) : 775-777. 被引量:1
  • 7Letendre L J, Kunda SA, Gallagher D J, et al. Method for preparing valdecoxib and related benzenesulfonyl compounds: WO, 2003029230 [P]. 2003-04-10. 被引量:1
  • 8Di NL, Vitale P, Scilimati A, et al. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal [J]. dMed Chem, 2004, 47 (20) : 4881-4890. 被引量:1
  • 9Okitsu T, Sato K, Potewar TM, et al. Iodocyclization of hydroxylamine derivatives based on the control of oxidative aromatization leading to 2,5-dihydroisoxazoles and isoxazoles [J]. J Org Chem, 2011, 76 (9) : 3438-3449. 被引量:1

二级参考文献24

  • 1Tallcy JJ, Bertenshaw SR, Brown DL, et al. N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt,parecoxib sodium: A potent and selective inhibitor of COX-2 forparenteral administration. J Med Chem, 2000;43:1661 - 1663. 被引量:1
  • 2Hubbard R, Kuss M, Talwalkers S, et al. Evaluation of parecoxib.A new injectable cycooxygense-2-specific inhibitor for the treatment of pain. Ann Emerg Med, 2000;36(Suppl):S69. 被引量:1
  • 3Cheer SM, Goa KL. Parecoxib (parecoxib sodium). Drugs, 2001;61:1133-41. 被引量:1
  • 4Karim A, Laurent A, Slater ME, et al. A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects. J Clin Pharmacol, 2001;41:1111 -9. 被引量:1
  • 5Ibrahim A, Karim A, Feldman J,et al. The influence of parecoxib,a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam. Anesth Analg, 2002;95:667-73. 被引量:1
  • 6Barton SF, Langeland FF, Snabes MC, et aL Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology.2002;97:306-14. 被引量:1
  • 7Kenaan CA, Bikhazi GB, Deepika E, et al. Analgesic activity and safety of parecoxib in post-surgical patients: an interim report.Anesth Analg, 2001 ;92:$257. 被引量:1
  • 8Tang J, Li S, White PF, Chen X, et al. Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology,2002;96:1305 - 9. 被引量:1
  • 9Rasmussen GL, Steckner K, Hogue C, et al. Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. Am J Orthop,.2002;31:336--43. 被引量:1
  • 10Daniels SE, Grossman EH, Kuss ME, et al. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther, 2001 ;23:1018 - 31. 被引量:1

共引文献75

同被引文献43

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部